Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01583478|
Recruitment Status : Unknown
Verified September 2014 by Corey S. Maas, M.D., The Maas Clinic.
Recruitment status was: Recruiting
First Posted : April 24, 2012
Last Update Posted : September 30, 2014
The Maas Clinic
Merz North America, Inc.
Information provided by (Responsible Party):
Corey S. Maas, M.D., The Maas Clinic
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||October 2015|
|Estimated Study Completion Date :||December 2015|